These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22372498)

  • 21. Homeostatic chemokine receptors and organ-specific metastasis.
    Zlotnik A; Burkhardt AM; Homey B
    Nat Rev Immunol; 2011 Aug; 11(9):597-606. PubMed ID: 21866172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The chemokine network, a newly discovered target in high grade gliomas.
    Domanska UM; Kruizinga RC; den Dunnen WF; Timmer-Bosscha H; de Vries EG; Walenkamp AM
    Crit Rev Oncol Hematol; 2011 Aug; 79(2):154-63. PubMed ID: 20709564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted therapies for pancreatic cancer.
    Ma Q
    Curr Pharm Des; 2012; 18(17):2393-4. PubMed ID: 22372496
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemokines: new, key players in the pathobiology of pancreatic cancer.
    Hedin KE
    Int J Gastrointest Cancer; 2002; 31(1-3):23-9. PubMed ID: 12622412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The chemokine system and cancer.
    Balkwill FR
    J Pathol; 2012 Jan; 226(2):148-57. PubMed ID: 21989643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer and the chemokine network.
    Balkwill F
    Nat Rev Cancer; 2004 Jul; 4(7):540-50. PubMed ID: 15229479
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer.
    Kleeff J; Kusama T; Rossi DL; Ishiwata T; Maruyama H; Friess H; Büchler MW; Zlotnik A; Korc M
    Int J Cancer; 1999 May; 81(4):650-7. PubMed ID: 10225458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization.
    Marcuzzi E; Angioni R; Molon B; Calì B
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30591657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-tumor effects of a 'human & mouse cross-reactive' anti-ADAM17 antibody in a pancreatic cancer model in vivo.
    Ye J; Yuen SM; Murphy G; Xie R; Kwok HF
    Eur J Pharm Sci; 2017 Dec; 110():62-69. PubMed ID: 28554668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer-associated fibroblasts in pancreatic adenocarcinoma.
    Pan B; Liao Q; Niu Z; Zhou L; Zhao Y
    Future Oncol; 2015 Sep; 11(18):2603-10. PubMed ID: 26284509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Wnt/β-catenin signaling in drug resistance of pancreatic cancer.
    Cui J; Jiang W; Wang S; Wang L; Xie K
    Curr Pharm Des; 2012; 18(17):2464-71. PubMed ID: 22372504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-translational control of chemokines: a role for decoy receptors?
    Comerford I; Nibbs RJ
    Immunol Lett; 2005 Jan; 96(2):163-74. PubMed ID: 15585320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Chemokines in Thyroid Carcinoma.
    Yapa S; Mulla O; Green V; England J; Greenman J
    Thyroid; 2017 Nov; 27(11):1347-1359. PubMed ID: 28891394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer.
    Marchesi F; Locatelli M; Solinas G; Erreni M; Allavena P; Mantovani A
    J Neuroimmunol; 2010 Jul; 224(1-2):39-44. PubMed ID: 20630606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral macrophage inflammatory protein-II and fractalkine (CX3CL1) chimeras identify molecular determinants of affinity, efficacy, and selectivity at CX3CR1.
    Davis CN; Zujovic V; Harrison JK
    Mol Pharmacol; 2004 Dec; 66(6):1431-9. PubMed ID: 15361546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of CX
    Stout MC; Narayan S; Pillet ES; Salvino JM; Campbell PM
    Biochem Biophys Res Commun; 2018 Jan; 495(3):2264-2269. PubMed ID: 29274778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The toxicology of chemokine inhibition.
    Schroff RW; Touvay C; Culler MD; Dong JZ; Taylor JE; Thurieau C; McKilligin E
    Mini Rev Med Chem; 2005 Sep; 5(9):849-55. PubMed ID: 16178726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical chemokine receptors in cancer: friends or foes?
    Massara M; Bonavita O; Mantovani A; Locati M; Bonecchi R
    J Leukoc Biol; 2016 Jun; 99(6):927-33. PubMed ID: 26908826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemokine signaling defines novel targets for therapeutic intervention.
    Rodríguez-Frade JM; Martínez-A C; Mellado M
    Mini Rev Med Chem; 2005 Sep; 5(9):781-9. PubMed ID: 16178721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of Ras signalling reduces neutrophil infiltration and tissue damage in severe acute pancreatitis.
    Yu C; Merza M; Luo L; Thorlacius H
    Eur J Pharmacol; 2015 Jan; 746():245-51. PubMed ID: 25460024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.